|
University Hospitals of Cleveland, which in February halted its
heart transplant program after poor results, has suspended its
chief lung transplant surgeon creating new uncertainty about the
future of its cardiothoracic transplant program.
Dr. Thomas Kirby, who was recruited from the Cleveland Clinic
in 1998, was suspended after the hospital claimed he violated
unspecified provisions of its code of conduct and policies. He
performed 24 transplants during his tenure at University Hospitals.
The latest development comes amid "management troubles and
political infighting among heart and chest surgeons" which
the Cleveland Plain Dealer reports have "plagued cardiac
surgery" since Kirby and Dr. Robert Stewart were lured from
the Cleveland Clinic with million dollar contracts and made co-chiefs
of cardiothoracic surgery.
With Kirby's
suspension, the six patients currently on the waiting list for
lung transplants at University Hospitals are expected to be given
the option of joining the waiting list at the Cleveland Clinic.
However, on
May 3rd Kirby sued to regain his job, contending his removal put
waiting-list patients and post-transplant patients under his care
at risk. He asked a Cuyahoga Common Pleas judge to order the hospital
to reinstate him, at least pending an internal hospital appeal.
Meanwhile,
amid the growing turmoil, Dr. James Schulak, chairman of surgery
at University Hospitals, said a review of the unusually high incidence
of deaths during 2001 in the heart transplant program (see earlier
Medical Week story) has been completed,
and the program may be restarted shortly.
"The
review basically stated that they didn't see any major problems,"
Schulak said. "And there is a strong recommendation from
the outside reviewers that the program has an experienced staff,
the protocols are in line with everything that's being done appropriately
across the country, and there's no reason not to restart it."
University
Hospitals will have to file a new application to revive Medicare
certification for the heart transplant program, and Medicare will
not pay for transplants until approval is granted.
Other
sources: University Hospitals, Cleveland Plain Dealer
|